Stocks
Health Care
rapt
RAPT Therapeutics
NASDAQ: RAPT
+22.46 (+63.99%)
57.56
USD
At close at Jan 20, 21:43 UTC
Income Statement
Revenue
-
Gross Profit
-
Operating Income
-136.10M
Pretax Income
-105.64M
Net Income
-129.87M
EBITDA
-126.33M
EBIT
-129.87M
Earnings Per Share
-25.52
Balance Sheet
Cash & Cash Equivalents
72.51M
Total Debt
5.42M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
131.37M
Book Value Per Share
30.12
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.